Tokyo Tape
Sign in
← Takeda Pharmaceutical

Quarterly report · Q1

4502.TEDINET S100RGTX
Period2023-04-01 → 2023-06-30
Filed2023-08-01
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥1.06T2023-04-01 → 2023-06-30Cons.Revenue IFRS
Revenue¥4.03T2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥972.5bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Operating income¥168.6bn2023-04-01 → 2023-06-30Cons.Operating profit loss IFRS
Operating income¥150.5bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Profit before tax¥135.0bn2023-04-01 → 2023-06-30Cons.Profit loss before tax IFRS
Profit before tax¥375.1bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥155.5bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥89.4bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥317.0bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥105.0bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥89.4bn2023-04-01 → 2023-06-30Cons.Profit loss IFRS
Net income¥317.0bn2022-04-01 → 2023-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥105.0bn2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Total assets¥14.79Tat 2023-06-30Cons.Assets IFRS
Total assets¥13.96Tat 2023-03-31Cons.Assets IFRS
Total assets¥14.07Tat 2022-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥7.87Tat 2023-06-30Cons.Liabilities IFRS
Total liabilities¥7.60Tat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥6.92Tat 2023-06-30Cons.Equity IFRS
Net assets / equity¥6.35Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥6.32Tat 2022-06-30Cons.Equity IFRS
Net assets / equity¥5.68Tat 2022-03-31dCons.Equity IFRS
Equity (owners)¥6.92Tat 2023-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥6.35Tat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥316.4bnat 2023-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥533.5bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥646.0bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥849.7bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥92.4bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥977.2bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥84.2bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥266.5bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥607.1bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥94.7bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥57.8bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥709.1bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥215.7bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥57.512023-04-01 → 2023-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥204.292022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥67.942022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥57.122023-04-01 → 2023-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥201.942022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥67.562022-04-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio46.8%at 2023-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio45.5%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio44.9%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 625
ItemContextValueUnit
Comprehensive income IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_RetainedEarningsIFRSMember105014000000JPY
Comprehensive income IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember722137000000JPY
Comprehensive income IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-225000000JPY
Issuance of new shares ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember14000000JPY
Issuance of new shares ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember14000000JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember-5000000JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember-27045000000JPY
Dividends ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-138218000000JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember15213000000JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-4679000000JPY
Share based compensation ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember12292000000JPY
Exercise of share based awards ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember-13838000000JPY
Exercise of share based awards ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember13867000000JPY
Total transactions with owners IFRSPrior1YTDDuration_ShareCapitalIFRSMember14000000JPY
Total transactions with owners IFRSPrior1YTDDuration_CapitalSurplusIFRSMember-1537000000JPY
Total transactions with owners IFRSPrior1YTDDuration_TreasurySharesIFRSMember-13177000000JPY
Total transactions with owners IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-123005000000JPY
Total transactions with owners IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Total transactions with owners IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-4679000000JPY
Equity IFRSPrior1QuarterInstant_ShareCapitalIFRSMember1676277000000JPY
Equity IFRSPrior1QuarterInstant_CapitalSurplusIFRSMember1707336000000JPY
Equity IFRSPrior1QuarterInstant_TreasurySharesIFRSMember-129184000000JPY
Equity IFRSPrior1QuarterInstant_RetainedEarningsIFRSMember1459764000000JPY
Equity IFRSPrior1QuarterInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember1710399000000JPY
Equity IFRSPrior1QuarterInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember17163000000JPY
Equity IFRSPrior2YearInstant_EffectivePortionOfCashFlowHedgesIFRSMember-65901000000JPY
Equity IFRSPrior2YearInstant_jpcrp040300-q1r_E00919-000HedgingCostIFRSMember-6135000000JPY
Equity IFRSPrior2YearInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Equity IFRSPrior2YearInstant_OtherComponentsOfEquityIFRSMember934173000000JPY
Equity IFRSPrior2YearInstant_EquityAttributableToOwnersOfParentIFRSMember5683019000000JPY
Equity IFRSPrior2YearInstant_NonControllingInterestsIFRSMember504000000JPY
Equity IFRSPrior2YearInstant5683523000000JPY
Effect of hyperinflation IFRSPrior2YearInstant_OtherComponentsOfEquityIFRSMember4121000000JPY
Effect of hyperinflation IFRSPrior2YearInstant_EquityAttributableToOwnersOfParentIFRSMember2161000000JPY
Effect of hyperinflation IFRSPrior2YearInstant2161000000JPY
Restated balance IFRSPrior2YearInstant_EffectivePortionOfCashFlowHedgesIFRSMember-65901000000JPY
Restated balance IFRSPrior2YearInstant_jpcrp040300-q1r_E00919-000HedgingCostIFRSMember-6135000000JPY
Restated balance IFRSPrior2YearInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Restated balance IFRSPrior2YearInstant_OtherComponentsOfEquityIFRSMember938294000000JPY
Restated balance IFRSPrior2YearInstant_EquityAttributableToOwnersOfParentIFRSMember5685180000000JPY
Restated balance IFRSPrior2YearInstant_NonControllingInterestsIFRSMember504000000JPY
Restated balance IFRSPrior2YearInstant5685684000000JPY
Profit loss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember105014000000JPY
Profit loss IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember7000000JPY
Profit loss IFRSPrior1YTDDuration105021000000JPY
Other comprehensive income IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember-25473000000JPY
Other comprehensive income IFRSPrior1YTDDuration_jpcrp040300-q1r_E00919-000HedgingCostIFRSMember-27415000000JPY
Other comprehensive income IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember10533000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass